Rebuttal from Gerard F. Curley, John G. Laffey and Brian P. Kavanagh

Journal of Physiology

Volumn 591, Issue 11, 2013, Pages 2771-2772

  Curley, Gerard F ^a,b   Laffey, John G ^a,b   Kavanagh, Brian P ^b,c  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; SALBUTAMOL;

ACIDOSIS; ACUTE LUNG INJURY; ADULT RESPIRATORY DISTRESS SYNDROME; ARTIFICIAL VENTILATION; BREATHING RATE; CLINICAL TRIAL (TOPIC); CRITICALLY ILL PATIENT; DRUG CHOICE; DRUG SAFETY; DRUG WITHDRAWAL; HEART ARRHYTHMIA; HUMAN; HYPERCAPNIA; HYPERCAPNIC ACIDOSIS; IMMUNE DEFICIENCY; IMMUNE RESPONSE; LACTIC ACIDOSIS; LOW TIDAL VOLUME VENTILATION; LUNG PERFUSION; LUNG VASCULAR RESISTANCE; NOTE; PNEUMONIA; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RISK BENEFIT ANALYSIS; SEDATION; SEPSIS; TIDAL VOLUME; UNSPECIFIED SIDE EFFECT;

ANIMALS; HUMANS; HYPERCAPNIA; RESPIRATORY DISTRESS SYNDROME, ADULT;

EID: 84878446337     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2013.255638     Document Type: Note

References (12)

1. Amato MB, Barbas CS, Medeiros DM, Magaldi RB, Schettino GP, Lorenzi-Filho G, Kairalla RA, Deheinzelin D, Munoz C, Oliveira R, Takagaki TY & Carvalho CR (1998). Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome. N Engl J Med 338, 347-354.
2. Beitler JR, Hubmayr RD & Malhotra A (2013). CrossTalk opposing view: There is not added benefit to providing permissive hypercapnia in the treatment of ARDS. J Physiol 591, 2767-2769.
3. Brower RG, Shanholtz CB, Fessler HE, Shade DM, White P Jr, Wiener CM, Teeter JG, Dodd-o JM, Almog Y & Piantadosi S (1999). Prospective, randomized, controlled clinical trial comparing traditional versus reduced tidal volume ventilation in acute respiratory distress syndrome patients. Crit Care Med 27, 1492-1498.
4. Caples SM, Rasmussen DL, Lee WY, Wolfert MZ & Hubmayr RD (2009). Impact of buffering hypercapnic acidosis on cell wounding in ventilator-injured rat lungs. Am J Physiol Lung Cell Mol Physiol 296, L140-L144.
5. Chonghaile MN, Higgins BD, Costello J & Laffey JG (2008). Hypercapnic acidosis attenuates lung injury induced by established bacterial pneumonia. Anesthesiology 109, 837-848.
6. Higgins BD, Costello J, Contreras M, Hassett P, O'Toole D & Laffey JG (2009). Differential effects of buffered hypercapnia versus hypercapnic acidosis on shock and lung injury induced by systemic sepsis. Anesthesiology 111, 1317-1326.
7. Kantores C, McNamara PJ, Teixeira L, Engelberts D, Murthy P, Kavanagh BP & Jankov RP (2006). Therapeutic hypercapnia prevents chronic hypoxia-induced pulmonary hypertension in the newborn rat. Am J Physiol Lung Cell Mol Physiol 291, L912-L922.
8. Ketabchi F, Egemnazarov B, Schermuly RT, Ghofrani HA, Seeger W, Grimminger F, Shid-Moosavi M, Dehghani GA, Weissmann N & Sommer N (2009). Effects of hypercapnia with and without acidosis on hypoxic pulmonary vasoconstriction. Am J Physiol Lung Cell Mol Physiol 297, L977-L983.
9. Laffey JG, Engelberts D & Kavanagh BP (2000). Buffering hypercapnic acidosis worsens acute lung injury. Am J Respir Crit Care Med 161, 141-146.
10. Osman D, Monnet X, Castelain V, Anguel N, Warszawski J, Teboul JL & Richard C (2009). Incidence and prognostic value of right ventricular failure in acute respiratory distress syndrome. Intensive Care Med 35, 69-76.
11. Stewart TE, Meade MO, Cook DJ, Granton JT, Hodder RV, Lapinsky SE, Mazer CD, McLean RF, Rogovein TS, Schouten BD, Todd TR & Slutsky AS (1998). Evaluation of a ventilation strategy to prevent barotrauma in patients at high risk for acute respiratory distress syndrome. Pressure- and Volume-Limited Ventilation Strategy Group. N Engl J Med 338, 355-361.
12. Wang Z, Su F, Bruhn A, Yang X & Vincent JL (2008). Acute hypercapnia improves indices of tissue oxygenation more than dobutamine in septic shock. Am J Respir Crit Care Med 177, 178-183.